
FEMY Valuation
Femasys Inc
- Overview
- Forecast
- Valuation
- Earnings
FEMY Relative Valuation
FEMY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FEMY is overvalued; if below, it's undervalued.
Historical Valuation
Femasys Inc (FEMY) is now in the Fair zone, suggesting that its current forward PS ratio of 3.71 is considered Fairly compared with the five-year average of -2.22. The fair price of Femasys Inc (FEMY) is between 0.67 to 0.86 according to relative valuation methord.
Relative Value
Fair Zone
0.67-0.86
Current Price:0.84
Fair
-1.53
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Femasys Inc. (FEMY) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-1.78
EV/EBIT
Femasys Inc. (FEMY) has a current EV/EBIT of -1.78. The 5-year average EV/EBIT is -0.98. The thresholds are as follows: Strongly Undervalued below -4.90, Undervalued between -4.90 and -2.94, Fairly Valued between 0.98 and -2.94, Overvalued between 0.98 and 2.95, and Strongly Overvalued above 2.95. The current Forward EV/EBIT of -1.78 falls within the Historic Trend Line -Fairly Valued range.
3.57
PS
Femasys Inc. (FEMY) has a current PS of 3.57. The 5-year average PS is 15.47. The thresholds are as follows: Strongly Undervalued below -22.78, Undervalued between -22.78 and -3.65, Fairly Valued between 34.60 and -3.65, Overvalued between 34.60 and 53.72, and Strongly Overvalued above 53.72. The current Forward PS of 3.57 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Femasys Inc. (FEMY) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.13. The thresholds are as follows: Strongly Undervalued below -5.34, Undervalued between -5.34 and -3.24, Fairly Valued between 0.97 and -3.24, Overvalued between 0.97 and 3.07, and Strongly Overvalued above 3.07. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-1.79
P/FCF
Femasys Inc. (FEMY) has a current P/FCF of -1.79. The 5-year average P/FCF is -2.03. The thresholds are as follows: Strongly Undervalued below -5.73, Undervalued between -5.73 and -3.88, Fairly Valued between -0.18 and -3.88, Overvalued between -0.18 and 1.67, and Strongly Overvalued above 1.67. The current Forward P/FCF of -1.79 falls within the Historic Trend Line -Fairly Valued range.
Femasys Inc (FEMY) has a current Price-to-Book (P/B) ratio of 11.74. Compared to its 3-year average P/B ratio of 3.06 , the current P/B ratio is approximately 283.93% higher. Relative to its 5-year average P/B ratio of 2.69, the current P/B ratio is about 335.59% higher. Femasys Inc (FEMY) has a Forward Free Cash Flow (FCF) yield of approximately -69.81%. Compared to its 3-year average FCF yield of -74.08%, the current FCF yield is approximately -5.77% lower. Relative to its 5-year average FCF yield of -60.37% , the current FCF yield is about 15.64% lower.
11.37
P/B
Median3y
3.06
Median5y
2.69
-72.62
FCF Yield
Median3y
-74.08
Median5y
-60.37
Competitors Valuation Multiple
The average P/S ratio for FEMY's competitors is 0.96, providing a benchmark for relative valuation. Femasys Inc Corp (FEMY) exhibits a P/S ratio of 3.57, which is 271.87% above the industry average. Given its robust revenue growth of 25.86%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of FEMY decreased by 26.55% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -1.33K to -1.73K.
The secondary factor is the Revenue Growth, contributed 25.86%to the performance.
Overall, the performance of FEMY in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

KFFB
Kentucky First Federal Bancorp
2.930
USD
-1.01%

NRSN
Neurosense Therapeutics Ltd
1.740
USD
-5.95%

ENLV
Enlivex Therapeutics Ltd
1.540
USD
+8.45%

CODX
Co-Diagnostics Inc
0.257
USD
-1.54%

TRT
Trio-Tech International
5.400
USD
+1.69%

LVTX
LAVA Therapeutics NV
1.420
USD
-3.40%

LGVN
Longeveron Inc
1.580
USD
+1.28%

MXC
Mexco Energy Corp
8.370
USD
-2.22%

UTSI
UTStarcom Holdings Corp
2.490
USD
-1.19%
FAQ

Is Femasys Inc (FEMY) currently overvalued or undervalued?
Femasys Inc (FEMY) is now in the Fair zone, suggesting that its current forward PS ratio of 3.71 is considered Fairly compared with the five-year average of -2.22. The fair price of Femasys Inc (FEMY) is between 0.67 to 0.86 according to relative valuation methord.

What is Femasys Inc (FEMY) fair value?

How does FEMY's valuation metrics compare to the industry average?

What is the current P/B ratio for Femasys Inc (FEMY) as of Jul 31 2025?

What is the current FCF Yield for Femasys Inc (FEMY) as of Jul 31 2025?

What is the current Forward P/E ratio for Femasys Inc (FEMY) as of Jul 31 2025?
